Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression

Código QR

Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression

Masaki Kato,1 Toshifumi Kimura,2 Takeshi Kimura,3 Terufumi Hara3 1Department of Neuropsychiatry, Kansai Medical University, Moriguchi-shi, Osaka, Japan; 2Medical Affairs, 3Clinical Safety and PMS, Development and Medical Affairs Division, GlaxoSmithKline K.K., Shibuya-ku, Tokyo, Japan Objective:...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kato M, Kimura T, Hara T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/ee88181ec17b4414a31679391cedc50e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
por: Jara M, et al.
Publicado: (2013)

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
por: Kang RY, et al.
Publicado: (2015)

Psychometric properties of the Spanish version of the Clinical Outcomes in Routine Evaluation – Outcome Measure
por: Trujillo A, et al.
Publicado: (2016)

Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study
por: Katagiri H, et al.
Publicado: (2018)

Neuromodulation and antenatal depression: a review
por: Kim DR, et al.
Publicado: (2015)

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
por: Pawelczyk T, et al.
Publicado: (2015)

Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder
por: Lamberti M, et al.
Publicado: (2015)

Effect of depressive symptoms on the length of hospital stay among patients hospitalized for acute stroke in Japan
por: Sugawara N, et al.
Publicado: (2015)

Clinical preference for factors in treatment of geriatric depression
por: Riepe MW
Publicado: (2014)

Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes
por: Qu M, et al.
Publicado: (2015)

Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?
por: Celik Guzel E, et al.
Publicado: (2014)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi T, et al.
Publicado: (2017)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki A, et al.
Publicado: (2014)

Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
por: Terao T, et al.
Publicado: (2017)

Catatonia in Down syndrome; a treatable cause of regression
por: Ghaziuddin N, et al.
Publicado: (2015)

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele
por: Yin J, et al.
Publicado: (2019)

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
por: Babij R, et al.
Publicado: (2015)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
por: Yang X, et al.
Publicado: (2015)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima K, et al.
Publicado: (2013)

Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage
por: Li YQ, et al.
Publicado: (2015)

&nbsp;Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
por: Abrahamian H, et al.
Publicado: (2012)

Effect of music intervention on the cognitive and depression status of senior apartment residents in Taiwan
por: Tai SY, et al.
Publicado: (2015)

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report
por: Noda Y, et al.
Publicado: (2014)

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy
por: Bosak M, et al.
Publicado: (2015)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
por: Kamijima K, et al.
Publicado: (2013)

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East
por: Alkhadhari S, et al.
Publicado: (2015)

Defensive function of persecutory delusion and discrepancy between explicit and implicit self-esteem in schizophrenia: study using the Brief Implicit Association Test
por: Nakamura M, et al.
Publicado: (2014)

Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report
por: Terao T, et al.
Publicado: (2017)

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
por: Cai SL, et al.
Publicado: (2015)

Social cognitive and neurocognitive deficits in inpatients with unilateral thalamic lesions — pilot study
por: Wilkos E, et al.
Publicado: (2015)

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang HR, et al.
Publicado: (2015)

Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study
por: Hsu YC, et al.
Publicado: (2015)

The association of post-stroke anhedonia with salivary cortisol levels and stroke lesion in hippocampal/parahippocampal region
por: Terroni L, et al.
Publicado: (2015)

Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study
por: Gutiérrez-Fernández J, et al.
Publicado: (2015)

Trazodone effects on [3H]-paroxetine and &alpha;2-adrenoreceptors in platelets of patients with major depression
por: Donatella Marazziti, et al.
Publicado: (2010)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen JW, et al.
Publicado: (2018)

Neurobehavioral burden of multiple sclerosis with nanotheranostics
por: Sriramoju B, et al.
Publicado: (2015)

Neuroinflammatory responses to traumatic brain injury
por: Paiva WS, et al.
Publicado: (2015)

Impact of aerobic exercise on sleep and motor skills in children with autism spectrum disorders – a pilot study
por: Br, et al.
Publicado: (2015)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka M, et al.
Publicado: (2014)